AI-Guided Bronchoscopy Using the Broncho AI Navigator
Real-Time AI-Guided Bronchoscopy: A Two-Phase Clinical Study Evaluating Usability and Impact on Procedural Performance Metrics of the Broncho AI Navigator
This clinical investigation evaluates the Ambu Broncho AI Navigator, an investigational software system designed to provide real-time navigational support during bronchoscopy. The system uses artificial intelligence to identify and display airway anatomy during procedures and to help bronchoscopists track which airway segments have been examined.
The study is conducted at Odense University Hospital and consists of two phases. In Phase 2a, experienced bronchoscopists use the system during routine bronchoscopies to evaluate and optimize technical settings and usability. For this phase 45 patients will be enrolled. In Phase 2b, bronchoscopies are randomized (1:1) to be performed with or without the Broncho AI Navigator to evaluate the impact of AI guidance on procedural performance. For this phase 108 patients will be enrolled.
Adult patients undergoing elective bronchoscopy are enrolled, while the primary study subjects are the bronchoscopists performing the procedures. The study evaluates whether use of the Broncho AI Navigator improves bronchoscopy performance by increasing diagnostic completeness, improving structured progression through the bronchial tree, and reducing procedure time. The findings will support further development and future validation of the Broncho AI Navigator in clinical practice.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Christian Borbjerg Laursen, MD
- Phone Number: +45 3023 1114
- Email: Christian.b.laursen@rsyd.dk
Study Locations
-
-
Region Syddanmark
-
Odense, Region Syddanmark, Denmark, 5000
- Recruiting
- Odense University Hospital
-
Contact:
- Christian Borbjerg Laursen, MD
- Phone Number: +45 3023 1114
- Email: Christian.b.laursen@rsyd.dk
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Phase 2a (System calibration):
Inclusion Criteria:
- Patients indicated for bronchoscopy of central airways as per standard of care.
- Patients with an age of 18 years or above.
Exclusion Criteria:
- Patients who are unable to cooperate for bronchoscopy (e.g., patients with mental disorders, cognitive impairment, psychological disorder).
- Patients who are unable or unwilling to give informed consent.
- Patients with highly abnormal lung anatomy.
- Patients with conditions which significantly impact the visual appearance of the airway tissue, such as heavy bleeding, secretions, or inflammation.
- Patients who are pregnant or breastfeeding
- Patients previously enrolled in either phase 2a
Phase 2b (Randomized study):
Inclusion Criteria:
- Patients indicated for bronchoscopy of central airways as per standard of care.
- Patients with an age of 18 years or above.
Exclusion Criteria:
- Patients who are unable to cooperate for bronchoscopy (e.g., patients with mental disorders, cognitive impairment, psychological disorder).
- Patients who are unable or unwilling to give informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Broncho AI Navigator
|
The Broncho AI Navigator is an investigational software device designed to provide real-time navigational support during bronchoscopy. The system analyzes live bronchoscopy video using artificial intelligence to identify anatomical landmarks and bronchial segments and displays this information on a monitor to assist navigation through the tracheobronchial tree. The software is evaluated as an adjunct to standard bronchoscopy procedures. |
|
No Intervention: Standard Bronchoscopy
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic completeness
Time Frame: At the time of the procedure
|
Diagnostic completeness is defined as the bronchoscopist's ability to visualize all available tertiary bronchial segments (RB1, RB2, RB3, RB4, RB5, RB6, RB7, RB8, RB9, RB10, LB1+2, LB3, LB4, LB5, LB6, LB8, LB9, and LB10) using the bronchoscope. For the purpose of this investigation, a procedure is considered fully diagnostically complete (score of 1) if all tertiary segments are visualized. If any segments are not visualized, the procedure is deemed diagnostically incomplete (score of 0). |
At the time of the procedure
|
|
Structured progression
Time Frame: At the time of the procedure
|
The structured progression outcome is scored between 0 and 18, with 18 indicating 18 correct progressions. A point is awarded when the bronchoscopist visualizes one segment and then immediately proceeds to the succeeding segment (e.g., visualizing RB1 followed by RB2 results in a point, whereas RB2 followed by RB1 does not). |
At the time of the procedure
|
|
Procedure time
Time Frame: At the time of the procedure
|
Procedure time is defined as the duration required for the bronchoscopist to visualize all 18 segments, starting from the visualization of the first segment to the last. |
At the time of the procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- CIS-030
- 16-0300-55 (Other Identifier: Medical Research Ethics Committees (MREC), Denmark)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data (IPD) will not be made publicly available. The study includes clinical procedure data and video recordings collected for medical device development and evaluation. Data contain information that could increase the risk of re-identification, and sharing is restricted to protect participant privacy and confidentiality in accordance with applicable data protection requirements.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.